IBRX Immunitybio Inc
Company Analysis
Latest News
ImmunityBio Rallies 8%, Securing Broadest Global Anktiva Approval in UAE
ImmunityBio (IBRX) shares rose nearly 8% after the United Arab Emirates (UAE) granted marketing authorization for its cancer immunotherapy, Anktiva. The...
🟢 Immunitybio is trading 4.2% up today on technical rebound and broader market strength
Immunitybio is trading 4.2% up at $7.08 on a technical rebound following several weak sessions and a sharp move higher after-hours on July 29. • The advance...
🟢 Immunitybio is trading 5.2% up today, rebounding from recent weakness without a clear catalyst
Immunitybio is trading at $7.19 (5.2% up) in pre-market, rebounding from recent weakness following a strong after-hours move on July 29. • The move appears to...
🟢 Immunitybio is trading 7.3% up today, rebounding in after-hours despite no clear catalyst
Immunitybio is trading 7.3% up at $7.33 in after-hours sessions, rebounding from recent weakness despite a lack of fresh company-specific news. • No earnings...
🔴 Immunitybio is trading 4.1% down today, underperforming a bullish biotech sector
Immunitybio is trading at $6.71 (down 4.1%), underperforming a biotech sector that is currently up over 2% on M&A-driven optimism. • The move lacks a clearly...
🔴 Immunitybio is trading 4.3% down today as shares consolidate without fresh catalysts
Immunitybio is trading at $7.08, down 4.3% today as the stock appears to be consolidating following recent volatility and a lack of new company-specific...
🔴 Immunitybio is trading 5.0% down
Immunitybio is trading at $7.66, down 5.0% from a comparison close of $8.07 during regular trading. This is a price-action follow-up, so a separate catalyst...
🟢 Immunitybio Inc is trading 4.14% up
IBRX is trading at $7.80, up 4.14%.
🟢 Immunitybio is trading 4.1% up today amid sector-wide biotech strength
Immunitybio is trading 4.1% up today at $7.75 as biotechnology stocks rally, with the sector ETF gaining 2.17%. • The move appears driven by broader sector...
🔴 Immunitybio is trading 4% down today on continued FDA warning fallout over Anktiva claims
Immunitybio is trading 4% down today at $7.42 as the company faces ongoing pressure from an FDA warning letter regarding promotional claims for its bladder...
🔴 Immunitybio is trading 4.1% down today amid FDA warning letter fallout and lawsuit risk
Immunitybio is trading 4.1% down at $7.88 as traders continue to digest the impact of an FDA warning letter regarding Anktiva promotional practices and the...
ImmunityBio Gains Institutional Backing, Sparking Retail Hopes for Anktiva Sales
Institutional investors are significantly increasing their positions in ImmunityBio. Strategic Investment Solutions boosted its stake by more than 2,300%....
🔴 Immunitybio is trading 5.8% down today in a sharp pullback without a clear catalyst
Immunitybio is trading at $8.36 (-5.75%) in a sharp pullback from its prior close of $8.87 despite a lack of major company-specific news. • No earnings...
🟢 IBRX is trading 4.7% up today on ANKTIVA optimism and positive 2026 regulatory milestones
IBRX is trading 4.7% up at $9.18 as investors continue to re-rate the stock on strong sentiment around its ANKTIVA bladder cancer therapy and positive 2026...
🔴 IBRX is trading 5.3% down today on profit-taking and broader market weakness
IBRX is trading 5.3% down at $8.44 as investors lock in profits following a period of significant gains. • The stock's recent rally was fueled by optimism...
🟢 IBRX extends move to 5.4% up
IBRX is trading at $9.23, up 5.4% versus the comparison close of $8.76 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 IBRX soars 5% on Russell 1000 inclusion hopes and upcoming Anktiva catalysts
IBRX is trading 5% up today at $9.19, extending a strong multi-day rally as investors anticipate potential inclusion in the Russell 1000 index and forthcoming...
🟢 IBRX makes sharp 10.2% jump
IBRX is trading at $8.59, up 10.2% versus the comparison close of $7.79 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 IBRX extends move to 5.5% up
IBRX is trading at $8.22, up 5.5% versus the comparison close of $7.79 during regular trading. This is a price-movement alert; no separate company-specific...
🟢 IBRX is trading 4% up today on retail interest and short-squeeze speculation
IBRX is trading about 4% up now at $8.11 on elevated retail interest and short-squeeze speculation, extending its multi-day rebound while outperforming a...